IT
Iaso Therapeutics, Inc.
SEC filingBiotechnology · East Lansing, MI
Amount raised$570Ksold at filing
Total offering$1.8M$1.2M still open
Investors in the raise1count reported to the SEC
FiledJan 14, 2026first sale Jan 9, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Steve KuemmerieDirector
Robert ForgeyExecutive Officer, Director
Xuefei HuangExecutive Officer, Director
Donald ParfetDirector
Jeffrey WesleyDirector
Executive officers, directors and promoters as listed on the Form D.